Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010111 |
---|---|
Receipt number | R000011733 |
Scientific Title | Phase 2a trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine and fluoropyrimidine chemotherapy. |
Date of disclosure of the study information | 2013/03/11 |
Last modified on | 2016/10/03 09:50:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/02/25 12:00:42 | ||
2 | Update | 2013/03/11 08:33:23 | Recruitment status |
|
3 | Update | 2013/11/05 17:42:05 | Recruitment status |
|
4 | Update | 2014/05/16 09:43:33 | UMIN ID2 |
|
5 | Update | 2014/06/23 08:44:14 | Key secondary outcomes Key secondary outcomes |
|
6 | Update | 2014/06/23 08:44:48 | Target sample size |
|
7 | Update | 2014/06/23 08:52:04 | TEL Last name of contact person Last name of contact person Organization Organization Division name Division name TEL Organization Organization |
|
8 | Update | 2014/06/24 08:28:52 | Recruitment status |
|
9 | Update | 2015/02/25 09:51:03 | Recruitment status |
|
10 | Update | 2016/10/03 09:50:20 | Recruitment status |